No abstract available
MeSH terms
-
9,10-Dimethyl-1,2-benzanthracene / toxicity
-
Administration, Topical
-
Animals
-
Antineoplastic Agents / therapeutic use*
-
Carcinogens / toxicity
-
Carcinoma, Squamous Cell / chemically induced
-
Carcinoma, Squamous Cell / drug therapy*
-
Carcinoma, Squamous Cell / pathology
-
Cell Line
-
Cell Proliferation / drug effects
-
Fluorouracil / therapeutic use*
-
Humans
-
Imidazoles / adverse effects
-
Indoles / adverse effects
-
Melanoma / drug therapy*
-
Mice
-
Oximes / adverse effects
-
Proto-Oncogene Proteins B-raf / antagonists & inhibitors*
-
Skin Neoplasms / chemically induced
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / pathology
-
Sulfonamides / adverse effects
-
Tetradecanoylphorbol Acetate / toxicity
-
Vemurafenib
Substances
-
Antineoplastic Agents
-
Carcinogens
-
Imidazoles
-
Indoles
-
Oximes
-
PLX 4720
-
Sulfonamides
-
Vemurafenib
-
9,10-Dimethyl-1,2-benzanthracene
-
Braf protein, mouse
-
Proto-Oncogene Proteins B-raf
-
Tetradecanoylphorbol Acetate
-
dabrafenib
-
Fluorouracil